Henan Lingrui Pharmaceutical Co Ltd
SSE:600285

Watchlist Manager
Henan Lingrui Pharmaceutical Co Ltd Logo
Henan Lingrui Pharmaceutical Co Ltd
SSE:600285
Watchlist
Price: 20.81 CNY -3.88% Market Closed
Market Cap: 11.6B CNY
Have any thoughts about
Henan Lingrui Pharmaceutical Co Ltd?
Write Note

P/E
Price to Earnings

17.3
Current
18
Median
21.9
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
17.3
=
Market Cap
11.7B CNY
/
Net Income
675.8m CNY
All Countries
Close

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
16.9
2-Years Forward
P/E
14.4
3-Years Forward
P/E
12.3

See Also

Discover More